Company Filing History:
Years Active: 2018
Title: Suping Li - Innovator in Tumor Treatment
Introduction
Suping Li is a notable inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative treatments for tumors. His work focuses on creating agents that can disrupt tumor blood supply, which is crucial for effective cancer treatment.
Latest Patents
Suping Li holds a patent for a tumor vascular disrupting agent polypeptide, gene, expression vector, and its use. This invention relates to a polypeptide that has a specific amino acid sequence, which includes a truncated tissue factor (tTF) and a tumor-targeting molecule (pHLIP). The design ensures that both components retain their functionality while working together to disrupt blood supply to tumors, thereby aiding in cancer treatment.
Career Highlights
Li is associated with Beijing Hua'an Innovation Biotechnology Co., Ltd., where he continues to advance his research and development efforts. His innovative approach to tumor treatment has positioned him as a key figure in the biotechnology sector.
Collaborations
Some of his notable coworkers include Guangjun Nie and Yanhua Tian, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Suping Li's work in developing tumor vascular disrupting agents represents a significant advancement in cancer treatment. His innovative contributions continue to impact the field of biotechnology positively.